The present invention relates generally to nitric oxide releasing pharmaceutical compounds. More particularly, the present invention relates to pharmaceutical compositions that release nitric oxide under physiological conditions. In one embodiment, the present invention relates to new chemical compounds--diazeniumdiolates nitric oxide donors--that are based on ethambutol possessing physiological and biomedical activity.